logo
Select company
Select metric
$ 51.78MCore Assets
VS
Market
20
Sector
43
Industry
49
History
13
$ 4.16Close
$ 2.05 - $ 8.48 52-Week Range
Ticker Information

Ticker

ADVM

Company Name

ADVERUM BIOTECHNOLOGIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ADVERUM BIOTECHNOLOGIES INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADVM - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 96.18M$ 44.39M$ 51.78M$ 0
3/31/2025$ 137.65M$ 51.14M$ 86.52M$ 0
12/31/2024$ 179.84M$ 62.63M$ 117.21M$ 0
9/30/2024$ 234.38M$ 94.83M$ 139.55M$ 0
6/30/2024$ 253.8M$ 129.3M$ 124.51M$ 0
3/31/2024$ 267.83M$ 151.58M$ 116.24M$ 0
12/31/2023$ 173.01M$ 76.98M$ 96.03M$ 0
9/30/2023$ 196.77M$ 108.02M$ 88.75M$ 0
6/30/2023$ 241.43M$ 113.84M$ 127.59M$ 0
3/31/2023$ 275.58M$ 70.06M$ 205.52M$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) Core Assets stands at $ 434.02M.
  • Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average Core Assets has been $ 241.29M.
  • The median Core Assets for ADVERUM BIOTECHNOLOGIES INC during this period was $ 221.48M
  • ADVERUM BIOTECHNOLOGIES INC reached its highest Core Assets over the past 5 years at $ 472.57M.
  • The lowest Core Assets recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe $ 51.78M

ADVERUM BIOTECHNOLOGIES INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
DTIL : PRECISION BIOSCIENCES INC $ 23.52MRANI : RANI THERAPEUTICS HOLDINGS INC $ 6.68MRNXT : RENOVORX INC $ 1.33MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 1.73MPLUR : PLURI INC $ 26.44MLSTA : LISATA THERAPEUTICS INC $ 8.17MIGC : IGC PHARMA INC $ 5.28MCLSD : CLEARSIDE BIOMEDICAL INC $ 5.96MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ 9.74MRLYB : RALLYBIO CORP $ 41.56M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Assets [ $ 507.71M ] - Intangibles [ $ 0 ] - CashnEq [ $ 73.69M ]
(=) Core Assets [ $ 434.02M ]

ADVM - Core Assets, Last 5 years

$ 51.78M

Minimum

Jun 30, 2025

$ 472.57M

Maximum

Jun 30, 2021

$ 241.29M

Average

$ 221.48M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 805.95M with a standard deviation of $ 1.06B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.42B
average$ 805.95M
median$ 292.02M
std$ 1.06B